Atul Pande - Aug 17, 2022 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role: Director
Signature: /s/ Eva Renee Barnett, attorney-in-fact for Atul Pande
Stock symbol: IMVT
Transactions as of: Aug 17, 2022
Transactions value $: $0
Form type: 4
Date filed: 8/19/2022, 04:46 PM
Previous filing: Jun 16, 2022
Next filing: Oct 4, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IMVT	Common Stock	Award	$0	+21.1K	+34.01%	$0.00	83K	Aug 17, 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IMVT	Stock Option (right to buy)	Award	$0	+31.7K		$0.00	31.7K	Aug 17, 2022	Common Stock	31.7K	$4.99	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares underlying restricted stock units awards ("RSUs").
F2	The RSUs vest in their entirety one year after the date of grant on August 17, 2023, subject to the Reporting Person's continued service to the Issuer as of such date; provided that the Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.
F3	The shares underlying the options vest one year after the date of grant on August 17, 2023, subject to the Reporting Person's continuous service to the Issuer as of such date.